Altimmune, Inc. (ALT) — 8-K Filings

8-K Filings (12)

• Altimmune Files 8-K with Corporate Updates — Apr 16, 2026 Risk: low
  Altimmune, Inc. filed an 8-K on April 16, 2026, reporting amendments to its articles of incorporation or bylaws, submission of matters to a vote of security hol
• Altimmune, Inc. Files 8-K with Regulatory Updates — Dec 19, 2025 Risk: low
  Altimmune, Inc. filed an 8-K on December 19, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure, Other Event
• Altimmune Files 8-K: Board Changes and Financials — Dec 1, 2025 Risk: low
  Altimmune, Inc. filed an 8-K on November 30, 2025, reporting changes in its board of directors and officers, along with compensatory arrangements. The filing al
• Altimmune Appoints New Directors, Updates Executive Compensation — Oct 3, 2025 Risk: low
  Altimmune, Inc. announced on October 1, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two new directors,
• Altimmune Files 8-K on Security Holder Vote — Sep 25, 2025 Risk: low
  On September 25, 2025, Altimmune, Inc. filed an 8-K report. The filing indicates that the company is submitting matters to a vote of its security holders. No sp
• Altimmune Files 8-K on Financials — Aug 12, 2025 Risk: low
  Altimmune, Inc. filed an 8-K on August 12, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. T
• Altimmune, Inc. Files 8-K Report — Jun 26, 2025 Risk: low
  On June 26, 2025, Altimmune, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation
• Altimmune, Inc. Relocates Principal Executive Offices — Mar 13, 2025 Risk: low
  On March 13, 2025, Altimmune, Inc. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 910 Clopper Road, Suite 20
• Altimmune Appoints Dr. Scott Harris as Chief Medical Officer — Feb 25, 2025 Risk: medium
  Altimmune, Inc. announced on February 24, 2025, the appointment of Dr. Scott Harris as Chief Medical Officer, effective immediately. Dr. Harris previously serve
• Altimmune Sells Liver Disease Business for $75M — Dec 11, 2024 Risk: medium
  Altimmune, Inc. announced on November 15, 2024, that it has entered into a definitive agreement to sell its liver disease business, including its NASH and NASH-
• Altimmune Files 8-K for Security Holder Vote — Sep 26, 2024 Risk: low
  Altimmune, Inc. filed an 8-K on September 26, 2024, to report the submission of matters to a vote of its security holders. The filing does not contain specific
• Altimmune Appoints New CMO, Director; Reports Officer Compensation — Jun 26, 2024 Risk: medium
  Altimmune, Inc. announced on June 25, 2024, the appointment of Dr. Vipin Garg as Chief Medical Officer and the election of Dr. Amy Comstock, MD, to its Board of

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX